Crossref
journal-article
Elsevier BV
Annals of Oncology (78)
References
40
Referenced
332
10.1038/290261a0
/ Nature / Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts by Shih (1981)10.1126/science.2999974
/ Science / Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene by Coussens (1985)10.1126/science.2992089
/ Science / Amplification of a novel v-erbB-related gene in a human mammary carcinoma by King (1985)10.1016/0304-419X(94)90012-4
/ Biochem Biophys Acta Rev Cancer / The biology of erbB-2/neu/HER-2 and its role in cancer by Hynes (1994){'key': '10.1093/annonc/12.suppl_1.S3_bb0030', 'series-title': 'Advances in Cancer Research', 'first-page': '25', 'article-title': 'Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors', 'author': 'Klapper', 'year': '2000'}
/ Advances in Cancer Research / Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors by Klapper (2000)10.1126/science.3798106
/ Science / Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene by Slamon (1987)10.1002/stem.160413
/ Stem Cells / The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy by Ross (1998){'key': '10.1093/annonc/12.suppl_1.S3_bb0045', 'first-page': 'M25', 'article-title': 'The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: From orphanhood to multiple stromal ligands', 'volume': '1377', 'author': 'Tzahar', 'year': '1998', 'journal-title': 'BBA Rev Cancer'}
/ BBA Rev Cancer / The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: From orphanhood to multiple stromal ligands by Tzahar (1998)10.1146/annurev.cb.10.110194.001343
/ Annu Rev Cell Biol / Receptor protein-kinases and their signal transduction pathways by van de Geer (1994)10.1016/S0014-5793(97)00412-2
/ FEBS Lett / The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions by Alroy (1997)10.1128/MCB.18.10.6090
/ Mol Cell Biol / ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network by Pinkas-Kramarski (1998)10.1002/j.1460-2075.1996.tb00603.x
/ EMBO J / Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions by Pinkas-Kramarski (1996)10.1038/sj.onc.1201466
/ Oncogene / Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation by Pinkas-Kramarski (1997){'key': '10.1093/annonc/12.suppl_1.S3_bb0075', 'first-page': '181A', 'article-title': 'Development and characterization of a rhuMAb HER2 antibody assay for clinical evaluation of cytotoxic potency', 'volume': '38', 'author': 'Baly', 'year': '1997', 'journal-title': 'Proc Am Assoc Cancer Res'}
/ Proc Am Assoc Cancer Res / Development and characterization of a rhuMAb HER2 antibody assay for clinical evaluation of cytotoxic potency by Baly (1997)10.1016/S0896-6273(00)80324-4
/ Neuron / Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis by Burden (1997)10.1128/MCB.16.10.5276
/ Mol Cell Biol / A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor by Tzahar (1996)10.1093/emboj/17.20.5948
/ EMBOJ / Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network by Tzahar (1998)10.1073/pnas.96.9.4995
/ Proc Natl Acad Sci USA / The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-denved growth factors by Klapper (1999)10.1093/emboj/16.16.4938
/ EMBO J / Bivalence of EGF-like ligands drives the ErbB signaling network by Tzahar (1997)10.1002/j.1460-2075.1996.tb00356.x
/ EMBOJ / ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer by Karunagaren (1996)10.1016/S0021-9258(17)36676-0
/ J Biol Chem / Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin by Sliwkowski (1994)10.1074/jbc.271.9.5251
/ J Biol Chem / All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired by Baulida (1996)10.1073/pnas.91.17.8132
/ Proc Natl Acad Sci USA / Insect cell-expressed p180ErbB3 possesses an impaired tyrosine kinase activity by Guy (1994)10.1093/emboj/18.12.3348
/ EMBO J / The carboxyl terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing by Waterman (1999)10.1016/S0092-8674(85)80050-7
/ Cell / Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies by Drebin (1985)10.1073/pnas.88.19.8691
/ Proc Natl Acad Sci USA / Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth by Stancovski (1991)10.1073/pnas.92.8.3353
/ Proc Natl Acad Sci USA / Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake by Hurwitz (1995){'key': '10.1093/annonc/12.suppl_1.S3_bb0145', 'first-page': '2771', 'article-title': 'Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies', 'volume': '52', 'author': 'Kasprzyk', 'year': '1992', 'journal-title': 'Cancer Res'}
/ Cancer Res / Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies by Kasprzyk (1992)10.1046/j.1440-1711.1998.00768.x
/ Immunol Cell Biol / c-Cbl: A regulator of T-cell receptor-mediated signaling by Thien (1998)10.1101/gad.12.23.3663
/ Genes Dev / c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor by Levkowitz (1998){'key': '10.1093/annonc/12.suppl_1.S3_bb0160', 'first-page': '1117', 'article-title': 'Coupling of the c-Cbl protooncogene product to ErbB-1 /EGF-receptor but not to other ErbB proteins', 'volume': '12', 'author': 'Levkowitz', 'year': '1996', 'journal-title': 'Oncogene'}
/ Oncogene / Coupling of the c-Cbl protooncogene product to ErbB-1 /EGF-receptor but not to other ErbB proteins by Levkowitz (1996)10.1016/S1097-2765(00)80231-2
/ Mol Cell / Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl /Sli-1 by Levkowitz (1999)10.1074/jbc.273.22.13819
/ J Biol Chem / Alternative mtracellular routing of ErbB receptors may determine signaling potency by Waterman (1998){'key': '10.1093/annonc/12.suppl_1.S3_bb0175', 'first-page': '63', 'article-title': 'Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization', 'volume': '13', 'author': 'Pauletti', 'year': '1996', 'journal-title': 'Oncogene'}
/ Oncogene / Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization by Pauletti (1996)10.1016/S0140-6736(87)92736-X
/ Lancet / Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: Immunohistological assessment correlates with gene amplification by Venter (1987)10.1126/science.2470152
/ Science / Studies of the HER-2/neu protooncogene in human breast and ovarian cancer by Slamon (1989)10.1016/0046-8177(95)90163-9
/ Hum Pathol / Neu overexpression correlates with extent of disease in large-cell ductal in situ carcinoma of the breast by De Potter (1995)10.1073/pnas.89.10.4285
/ Proc Natl Acad Sci USA / Humanization of the anti-p185HER2 antibody for human cancer therapy by Carter (1992){'key': '10.1093/annonc/12.suppl_1.S3_bb0200', 'first-page': '2825', 'article-title': 'Recombinant humanized anti-HER2 antibody (HerceptinTM) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts', 'volume': '58', 'author': 'Baselga', 'year': '1998', 'journal-title': 'Cancer Res'}
/ Cancer Res / Recombinant humanized anti-HER2 antibody (HerceptinTM) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts by Baselga (1998){'key': '10.1093/annonc/12.suppl_1.S3_bb0205', 'first-page': '1829', 'article-title': 'Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells', 'volume': '54', 'author': 'Pietras', 'year': '1994', 'journal-title': 'Oncogene'}
/ Oncogene / Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells by Pietras (1994)
Dates
Type | When |
---|---|
Created | 13 years, 7 months ago (Jan. 20, 2012, 12:04 a.m.) |
Deposited | 3 years, 8 months ago (Dec. 26, 2021, 9:21 a.m.) |
Indexed | 3 weeks ago (Aug. 6, 2025, 9:55 a.m.) |
Issued | 24 years, 7 months ago (Jan. 1, 2001) |
Published | 24 years, 7 months ago (Jan. 1, 2001) |
Published Print | 24 years, 7 months ago (Jan. 1, 2001) |